Junfeng Liu

6PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Integrated hypoxia and metabolic gene signature to predict clinical outcomes and therapeutic vulnerabilities in lung adenocarcinoma.

|Jul 08, 2026
Ensartinib in Resected <i>ALK</i>-Positive Non-Small-Cell Lung Cancer.

|May 19, 2026
Risk factors for non-curative resection after endoscopic submucosal dissection for early esophageal lesions and analysis of secondary treatment efficacy.

|Mar 02, 2026
PET/CT-Guided Neoadjuvant Tislelizumab plus Chemotherapy/Chemoradiotherapy for Resectable Esophageal Squamous Cell Carcinoma: RATIONALE-213 Final Analysis.

Yushang Yang, Xiaolong Yan, Hongjing Jiang

|May 21, 2024
Citrulline facilitates the glycolysis, proliferation, and metastasis of lung cancer cells by regulating RAB3C.

Qingjun Meng, Yanguang Li, Zhen Sun

|Sep 17, 2021
The effects of acetylcholine on intracellular calcium fluorescence in smooth muscle cells of human esophagogastric junction cultured in vitro.

Yang Gao, Jun-Feng Liu, Chao Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Yang Gao

1 joint publications

Chao Zhang

1 joint publications

Yushang Yang

1 joint publications

Xiaolong Yan